Viewing Study NCT00667420


Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2026-02-28 @ 5:33 AM
Study NCT ID: NCT00667420
Status: TERMINATED
Last Update Posted: 2014-07-04
First Post: 2008-04-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma
Sponsor: Massachusetts General Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Adenocarcinoma View
None Gastric Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None gastric View
None esophageal View
None panitumumab View